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Abstract
Introduction: Primary hyperaldosteronism is only rarely caused by unilateral adrenal hyperplasia.
Case presentation: A 73-year-old hypertensive Greek man (on 10 mg amlodipine for the last ten
years) presented in the emergency department with severe muscle weakness of all limbs. The initial
physical and laboratory examination revealed normal blood pressure, muscle weakness, severe
hypokalemia, sinus rhythm and U wave, rhabdomyolysis and metabolic alkalosis. The patient was
immediately treated with intravenous administration of potassium-rich solutions, 25 mg
spironolactone with progressive dose titration up to 100 mg. Because of high arterial blood
pressure, irbesartan was added. On day 6, muscle weakness was completely restored with decrease
of arterial blood pressure and further improvement of laboratory tests. The combination of
hypokalemia with arterial hypertension raised the suspicion of primary hyperaldosteronism;
therefore, we performed abdomen computed tomography scan, which revealed a nodular mass
(15 mm in diameter) in the left adrenal gland. Plasma renin activity was in the lower normal range
with a three-fold increase of plasma aldosterone concentration. We performed total resection of the
left adrenal gland and the histopathological examination revealed hyperplasia of the left adrenal gland.
Conclusion: This report presents a rare case of an elderly patient under antihypertensive treatment
the last ten years for essential hypertension, who admitted to our emergency department with
hypokalemia – induced myopathy as first manifestation of primary hyperaldosteronism due to
unilateral adrenal hyperplasia.
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Primary hyperaldosteronism (PH) or Conn’s disease was
first described by Jerome W. Conn in 1955 in a 34-year-old
woman with arterial hypertension, intermittent paralysis,
hypokalemia and metabolic alkalosis [1-3]. The most
frequent findings of PH are arterial hypertension, hypo-
kalaemia, suppressed plasma renin activity (PRA) and
increased plasma aldosterone concentration (PAC) [1-3].
In most cases (>90%), PH is attributed to bilateral adrenal
hyperplasia (idiopathic hyperaldosteronism-IHA) or
aldosterone-producing adenoma (APA). Unilateral adre-
nal hyperplasia (UAH) is a rare cause of PH [1,2].
In this paper we report the case of a 73-year-old man with
a history of arterial hypertension for the last 10 years
treated with 10 mg amlodipine. He presented to our
emergency department with severe muscle weakness of all
limbs, which was actually the first manifestation of PH
caused by UAH.
Case presentation
A 73-year-old hypertensive Greek man (on 10 mg amlodi-
pine for the last ten years) presented to our emergency
department with severe muscle weakness of all limbs. The
initial physical and laboratory examination revealed
arterial blood pressure (140/80 mmHg), muscle weakness,
severe hypokalemia (K
+ = 1.6 meq/l), sinus rhythm and
U wave, rhabdomyolysis (Creatinine Phosphokinase,
CPK = 7463 U/l) and metabolic alkalosis (arterial blood
gasses: pH = 7,546, pCO2 = 43, pO2 = 61, HCO3
- = 37,
SO2 = 93%).Becauseofthelowserumpotassiumleveland
clinicalsuspicionofPHandtothefactthatallthenecessary
laboratory examinations had been already done, the
patient was immediately treated with intravenous admin-
istration of potassium-rich solutions, 25 mg spironolac-
tone with progressive dose titration up to 100 mg.
On day 3 and under a daily dose of 100 mgs spirinolactone,
the laboratory findings were: K
+ = 3 meq/l, CPK = 3604 U/l,
arterial blood gas: pH = 7.571, pCO2 =3 7 . 2 ,p O 2 = 70.1,
HCO3
- = 34.5,SO2 = 97.3%.Becauseofuncontrolledhyper-
tension (185/105 mmHg), 300 mgs irbesartan were further
added. On day 6, muscle weakness was completely restored
withdecreaseofarterialbloodpressure(155/90 mmHg)and
further improvement of laboratory tests (K
+ =3 . 9
meq/l, CPK = 1362 U/l, arterial blood gasses: pH = 7.49,
pCO2 = 38.6, pO2 =7 7 . 5 ,H C O 3
- = 29.1, SO2 =9 7 . 6 % ) .
The combination of hypokalemia with arterial hyperten-
sionraisedthesuspicionofPH;therefore,weperformedan
abdominal Computed Tomography scan (CT), which
revealed a nodular mass (15 mm in diameter) in the left
adrenal gland (Figure 1). PRA was in the lower normal
range(0.7ng/ml/h,normalvalues:0.2-2.8ng/ml/h)witha
three-fold increase of PAC (498 pg/ml, normal values:
10-160pg/ml)andtheratioPAC/PRAwas71.14ng/dl/ng/
ml/h. Moreover plasma concentrations of adrenocortico-
tropic hormone (ACTH) and cortisol were (34 pg/ml,
normal values: 0-40 pg/ml) and (348 nmol/l, normal
values: 171-536 nmol/l) respectively. Our suspicion of PH
was further supported by the combination of hypokalemia
and hyperkaliuria (64 meq/24 hrs, normal values:
23-127 meq/24 hrs), whereas urinary sodium concentra-
tion was within normal range (106 meq/24 hrs, normal
values: 40-220 meq/24 hrs). We notice that all the above
assays, except the urine analysis done prior to starting any
treatment.Onaccountoftheclinicalsuspicionofunilateral
APA of the left adrenal gland we did not supply the salt
loading suppression tests (acute into 4 hours, intravenous
saline loading as well as a 4-day fludrocortisone adminis-
tration),inordertoconfirmorexcludethediagnosisofPH.
Furthermore, we did not perform specific imaging exam-
inations including Magnetic Resonance Imaging (MRI) of
the adrenal glands and scintigraphy with iodine-131.
We performed total resection of the left adrenal gland
(Figure 2). The histological findings of the specimen were
consistent with mild grade nodular adrenal cortical
hyperplasia and confirmed the diagnosis of PH. The
microscopy revealed many adrenal tissue specimens with
cortical hyperplasia. Nodular pattern and nodules were
separated by fine connective tissue septa. Most cells were
clear cells and form cords and nests. In one specimen an
adrenal cortical nodule in adipose tissue was observed.
Focally in connective tissue bands perivascular infiltration
was observed (Figures 3, 4).
Six months after discharge, the patient is asymptomatic,
normotensive and normokalemic without any treatment.
Figure 1. Nodular mass (diameter approximately 15 mm) on
the left adrenal gland. The right adrenal gland appears normal.
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PH constitutes the most frequent cause of secondary
arterial hypertension [1,2]. The incidence of PH ranged
between 0.05-2% in the past decades but currently ranges
between 5-10%, probably due to more efficient diagnostic
approach nowadays [1,2,4,5]. The rate of PH among
patients with resistant hypertension is approximately 20%
[5] and the age of diagnosis is usually between 20-60 years
[2]. Furthermore, a recent study reported that all patients
with PH due to UAH were hypertensive and the median
age was 49 (range: 10-62) years [6]. Table 1 presents the
frequency of the different causes of PH [1,2].
Severe muscle weakness is a classic manifestation of PH
and is usually related to coexistent hypokalemia [7]. On
the contrary, in a review study of 30 patients with PH due
to UAH, myopathy is not reported as a characteristic
manifestation [6]. In the majority of cases presenting with
myopathy, paralysis commonly affects the limb muscles
[7]. Our patient presented with severe muscle weakness of
all limbs and plasma potassium levels was 1.6 meq/l. In
a study by Huang et al on patients with PH, plasma
potassium was lower in patients with paralytic myopathy
compared to those without (1.8 ± 0.3 mmol/L vs.
2.3 ± 0.4 mmol/L respectively) [7]. Furthermore a study
by Crawhall et al. concluded that patients with severe
hypokalemia - such as observed in PH accompanied with
muscle weakness - may have elevated CPK directly related
to preexisting hypokalemia [8]. Table 2 shows the change
of potassium and CPK levels during the first week of
hospitalization of our patient.
Hypokalemia is one of the most frequent findings of PH
[2]. In the study by Goh et al, most patients with PH due to
UAH were hypokalemic at presentation, with a median
serum potassium level of 2.8 (range: 1.4-3.9) mmol/l,
whereas in comparison with our patient, only one patient
had potassium levels lower than 1.6 mmol/l and two
equalto1,6mmol/l[6].In1965,Connetal.firstsuggested
Figure 2. Operative specimen of the left adrenal gland.
Figure 3. An adrenal cortical nodule in adipose tissue
(HE × 40).
Figure 4. Fine connective tissue septa separate adrenal
cortical clear cells nodules (HE × 100).
Table 1. Causes of primary hyperaldosteronism
Causes of primary hyperaldosteronism Frequency (%)
Idiopathic hyperaldosteronism 65
Aldosterone-producing adenoma 30
Primary unilateral adrenal hyperplasia 3
Aldosterone-producing adrenocortical carcinoma <1
Aldosterone-producing ovarian tumor <1
Familiar hyperaldosteronism <1
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PH something that was later confirmed by other studies,
which showed that most patients with PH were normoka-
lemic [2]. Recently another Greek study showed that
hypokalemia was present in 83 (45.6%) patients with
resistant hypertension due to PH [5]. On the contrary, in
a study by Pekarske et al, [4] hypokalemia constituted one
of the most frequent findings among patients with PH.
Moreover, Loh et al. reported that among hypertensive
patients with primary hyperaldosteronism, hypokalemia
can present many years after the appearance of arterial
hypertension [9].
There are some specific tests, which confirm the diagnosis
of PH [1,2,10]. In our case we did not perform any of
these tests, on the one hand because of the severity of
hypokalemia and the clinical status of the patient and on
the other because of the obvious representation of a
nodular mass on the left adrenal gland in abdominal CT.
On the contrary, we administered at once from the 1
st day
of hospitalization, spironolactone (25 mg per day) with
progressive titration of dose in the next days. Furthermore,
it is known that for the reliability of these specific tests, it is
necessary the interruption of spironolactone at least for
six weeks, or its administration when these tests have
completed [1,2]. In addition, in a study by Karagiannis
et al, [11] was reported that in many cases like ours, when
the clinical status of the patient suffered PH is very severe,
an urgent therapeutic procedure is necessary.
Finally, in accordance with other findings, in most cases,
the imaging control (CT-MRI or scintigraphy) contributes
to the diagnosis and helps in deciding the appropriate
mode of treatment [1]. In the study by Young et al,
[12] was reported that a unilateral adrenal macroadenoma
(>1 cm) detected by CT is highly suggestive of APA, so that
further evaluation to distinguish between APA and IHA is
probably not necessary. On the contrary, in the study by
Tamura et al, [13] it was reported that in many cases of
small size APA (microadenomas) are undetectable by
classical imaging tests for a long period and it demands
further investigation with specific tests. In accordance to
the laboratory and imaging examinations (nodular mass
diameter approximately 15 mm on the left adrenal gland)
and personal history of the patient (arterial hypertension
since last 10 years), we did not perform specific tests. The
patient was transferred to the surgical department and
had unilateral adrenal surgery. The histopathological
examination revealed hyperplasia of the left adrenal glad
and confirmed the diagnosis of PH.
PH is only rarely caused by UAH [3]. The possibility that
UAH can cause PH was suggested by Ross in 1965 [6].
Omura et al. reported that the prevalence of APA, IHA and
UAH was 4.9%, 1.2% and 0.1% respectively [14]. UAH
constitutes a rare cause of PH, which is difficult to diagnose
because imaging results are unreliable [15]. This rare cause
of PH usually mimicks an adrenal adenoma and is difficult
to diagnose prior to resection and histopathological
examination [3]. We notice, that in our case although the
CT showed a nodular mass on the left adrenal gland,
diameter approximately 15 mm, eventually the histopatho-
logical examination revealed hyperplasia of the left adrenal
glad. The pathogenesis of UAH is not clearly understood.
This disorder is thought to be a precursor of adenoma
formation or an intermediate state between APA and IHA
[15].
The treatment of choice for UAH is unilateral total
adrenalectomy [15,16] which may be complicated
by postoperative hyperkalemia due to secondary hypoal-
dosteronism; thus, serum potassium levels should be
monitored weekly for 4 weeks [1]. Typically, arterial
hypertension decreases substantially within 1 to 3 months
without antihypertensive treatment [1,2]. Nevertheless, a
recent study reported that patients with PH secondary to
UAH have excellent outcomes after surgical treatment [6].
Our patient did not develop any complication. Six months
after discharge, the patient is under periodical follow up.
The levels ofplasma potassium aswellas thearterial blood
pressure are normal without pharmaceutical treatment.
Conclusion
Summarising, this report presents a rare case of an elderly
patient under antihypertensive treatment the last ten years
for essential hypertension, who admitted to our emer-
gency department with hypokalemia – induced myopathy
as first manifestation of PH due to UAH.
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Table 2. Variation of serum potassium and CPK at the 1
st week of
hospitalization
Variation of serum potassium (meq/lt) and CPK (mg/dl)
Days 1 234567
Potassium 1,6 2,2 3 3,2 3,5 3,9 4,4
CPK 7463 6531 3604 3007 2816 1362 575
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